Genetics of Pancreatic Cancer and Its Implications on Therapy

被引:13
|
作者
Tatarian, Talar [1 ]
Winter, Jordan M. [2 ]
机构
[1] Thomas Jefferson Univ Hosp, Dept Surg, Jefferson Pancreas Biliary & Related Canc Ctr, Sidney Kimmel Med Coll, 1015 Walnut St,Suite 620, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ Hosp, Dept Surg, Jefferson Pancreas Biliary & Related Canc Ctr, Sidney Kimmel Med Coll, 1025 Walnut St,Suite 605, Philadelphia, PA 19107 USA
关键词
Pancreatic cancer; Genetics; Personalized medicine; Targeted therapy; PHASE-II TRIAL; GROWTH-FACTOR RECEPTOR; DUCTAL ADENOCARCINOMA; 1ST-LINE TREATMENT; PLUS GEMCITABINE; OPEN-LABEL; K-RAS; MUTATIONS; TRASTUZUMAB; KRAS;
D O I
10.1016/j.suc.2016.07.014
中图分类号
R61 [外科手术学];
学科分类号
摘要
Over the past decade, emerging technologies have provided new insights into the genomic landscape of pancreatic ductal adenocarcinoma (PDA). In addition to the commonly recognized genetic drivers of pancreatic carcinogenesis (KRAS, CDKN2A, TP53, SMAD4), new genes and pathways have been implicated. However, these efforts have not identified any new high-frequency actionable mutations, limiting the success of mutation-targeted therapy in PDA. This article provides a report on the current landscape of pancreas cancer genetics and targeted therapeutics.
引用
收藏
页码:1207 / +
页数:16
相关论文
共 50 条
  • [21] Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer
    Rachagani, Satyanarayana
    Macha, Muzafar A.
    Heimann, Nicholas
    Seshacharyulu, Parthasarathy
    Haridas, Dhanya
    Chugh, Seema
    Batra, Surinder K.
    ADVANCED DRUG DELIVERY REVIEWS, 2015, 81 : 16 - 33
  • [22] SMAD4 and its role in pancreatic cancer
    Xia, Xiang
    Wu, Weidong
    Huang, Chen
    Cen, Gang
    Jiang, Tao
    Cao, Jun
    Huang, Kejian
    Qiu, Zhengjun
    TUMOR BIOLOGY, 2015, 36 (01) : 111 - 119
  • [23] A comprehensive review of pancreatic cancer and its therapeutic challenges
    Jiang, Shan
    Fagman, Johan Bourghardt
    Ma, Yunyun
    Liu, Jian
    Vihav, Caroline
    Engstrom, Cecilia
    Liu, Beidong
    Chen, Changyan
    AGING-US, 2022, 14 (18): : 7635 - 7649
  • [24] Genetics and biology of pancreatic ductal adenocarcinoma
    Ying, Haoqiang
    Kimmelman, Alec C.
    Bardeesy, Nabeel
    Kalluri, Raghu
    Maitra, Anirban
    Depinho, Ronald A.
    GENES & DEVELOPMENT, 2025, 39 (1-2) : 36 - 63
  • [25] Pancreatic cancer stem cell biology and its therapeutic implications
    Bednar, Filip
    Simeone, Diane M.
    JOURNAL OF GASTROENTEROLOGY, 2011, 46 (12) : 1345 - 1352
  • [26] Advances in the Genetics and Biology of Pancreatic Cancer
    Aguirre, Andrew J.
    Collisson, Eric A.
    CANCER JOURNAL, 2017, 23 (06) : 315 - 320
  • [27] Total Neoadjuvant Therapy in Localized Pancreatic Cancer: Is More Better?
    Saude-Conde, Rita
    El Ghali, Benjelloun
    Navez, Julie
    Bouchart, Christelle
    Van Laethem, Jean-Luc
    CANCERS, 2024, 16 (13)
  • [28] Biomarkers in Pancreatic Cancer as Analytic Targets for Nanomediated Imaging and Therapy
    Grapa, Cristiana Maria
    Mocan, Lucian
    Crisan, Dana
    Florea, Mira
    Mocan, Teodora
    MATERIALS, 2021, 14 (11)
  • [29] An introduction to pancreatic adenocarcinoma genetics, pathology and therapy
    Kern, SE
    Hruban, RH
    Hidalgo, M
    Yeo, CJ
    CANCER BIOLOGY & THERAPY, 2002, 1 (06) : 607 - 613
  • [30] Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
    Deng, Daiyong
    Patel, Riya
    Chiang, Cheng-Yao
    Hou, Pingping
    CELLS, 2022, 11 (19)